Embolx, Inc.: Detailed Company Information & Corporate Profile
Summary
Embolx, Inc., founded in 2013, is an independent Medtech company headquartered in Sunnyvale, CA, operating within the San Francisco Bay Area.
The firm specializes in catheters and interventional devices for oncology, urology, gynecology, hematology, PAE, and BPH applications. With a lean team of 10 to 50 employees and annual revenue between $1 million and $10 million, Embolx delivers innovative solutions that support clinicians across the spectrum of minimally invasive procedures.
Leadership includes President & CEO Michael Allen, Sales Director Robert Hornak, Sr Engineering Manager Aaron Castillo, and several regional managers who drive sales and regulatory compliance for a growing product portfolio.
| Embolx, Inc. Website | embolx.com |
| Phone Number | 14089902949 |
| Industries | |
| Embolx, Inc. Headquarters Address | 530 Lakeside Drive, Sunnyvale, CA, 94085 US |
| Company Size | 10-50 employees |
| Specialities & Services | Catheters, Oncology, Interventional Radiology, medical devices, Urology, Gynecology, Hematology, PAE, BPH |
| DMA Code | San Francisco Bay Area |
| Founded | 2013 |
| Estimated Annual Revenue | $1 - 10M |
| Operating Status | Independent Company |
| Updated: | 2026-10-16 |
Workforce Turnover
Departmental sample breakdown
Length of Employment
Embolx, Inc.'s workforce includes employees across a wide range of tenure levels.
17% have been with the company for 3 to 4 years50% have been with the company for 5 to 7 years33% have been with the company for 8 to 10 years
Companies Similar to Embolx, Inc.
Embolx, Inc. Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
